Breaking News, Financial News

Financial Report: AMRI 


Decline in royalties impacts results

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AMRI 
   1Q Revenues: $59.3 million (flat) 1Q Earnings: $3.5 million (-46%) Comments: Contract revenue was $51.0 million in the quarter, up 10%. Royalties were $8.3 million, down 36% due to generic competition for Allegra in Japan. Discovery Services and Development / Small Scale Manufacturing (DDS) contract revenue for the first quarter was $19.5 million, a decrease of 3%. Decreases in Discovery revenues were partially offset by increases in Development/Small Scale Manufacturing. Large Scale ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters